)
PExA (PEXA) investor relations material
PExA Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Transitioning from a research instrument provider to a diagnostics-focused company, emphasizing early lung cancer detection and diagnostics, with a strategic focus on long-term value creation and technology development.
Instrument enables unique sampling from small airways, supporting biomarker discovery, pharmacogenetics, and diagnostics.
Revenue for Q3 2025 was 44,489 SEK, up from 31,503 SEK year-over-year; nine-month revenue reached 357,069 SEK, up from 251,201 SEK.
Fully guaranteed rights issue raised SEK 9.9 million, with most guarantors opting for shares, reflecting long-term confidence and securing funding for strategic development.
Expansion of customer base and collaborations, including first instrument placement and data-sharing agreement in Australia, and a pilot study at Danderyd Hospital.
Financial highlights
SEK 9.9 million raised in a fully guaranteed rights issue, improving liquidity and supporting development.
Q3 net sales increased 41% year-over-year; nine-month sales up 42%.
Q3 net loss was -2,574,777 SEK; nine-month net loss was -7,138,751 SEK, slightly improved from prior year.
Cash and cash equivalents at period end were 8.06 MSEK; equity ratio at period end was 82.5%.
Operating cash flow for Q3 was 6.37 MSEK; nine-month operating cash flow was 2.46 MSEK.
Outlook and guidance
Strategic focus on becoming a lung cancer diagnostics company, with ongoing validation and regulatory pathway development for CE-marking.
Funding from the rights issue enables continued development in three strategic focus areas.
Expectation of further updates on strategic direction and regulatory progress in the coming months.
Long-term goal is to enable earlier detection of lung diseases and expand into broader diagnostic markets.
Continued expansion in biomarker discovery, pharmacogenetics, and pharmacodynamics, with increasing interest from the pharmaceutical industry.
Next PExA earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)